Drug shortage: Amino Acid Injection (PREMASOL - SULFITE-FREE (AMINO ACID), TROPHAMINE, AMINOSYN-PF)
FDA lists 16 presentations as Current. Availability: Unavailable (3), Available (13). Reason: Shortage of an active ingredient; Shortage of an inactive ingredient component. Companies: Baxter Healthcare, B. Braun Medical Inc., Otsuka ICU Medical LLC.
- Published by source
- 2020-12-08
- First seen by Reality Radar
- 2026-10-22
- Last verified
- 2026-10-22
Affected
- Manufacturer
- Baxter Healthcare
- Products
- Amino Acid Injection PREMASOL - SULFITE-FREE (AMINO ACID) TROPHAMINE AMINOSYN-PF AMINOSYN II TRAVASOL PLENAMINE
Whether your exact unit is affected depends on the model, serial number and region in the official notice.
What the official notice says
Risk: Current — Unavailable
Remedy / actions:
- Estimated recovery: TBD. This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
- This product is distributed by ICU Medical. For questions regarding this product, please contact ICU Medical.
Is this affecting you?
Add what you own or use and Reality Radar will tell you when official changes match it — with evidence and next steps.
Sources
- openFDA Drug Shortages Tier A · official published 2020-12-08
Evidence ledger
Every piece of evidence we store is appended to a public hash chain, so later edits are detectable. Anyone can re-verify it.
| Entry | Kind | Observed | Evidence hash | Entry hash |
|---|---|---|---|---|
| #898 | new | 2026-10-22 | bf1a972e461d…f78d45 | ffb7d5ee6e1b…ea4b59 |
Chain head: #1094 edf3be25ec2e…478842